▶ 調査レポート

凍結乾燥注射製剤の世界市場分析・規模・シェア・成長・動向・予測:包装の種類別(使い捨てバイアル、ポイントオブケア再構成、特殊包装)、デリバリータイプ別(プレフィル希釈剤シリンジ、専用の再構成型デバイス、シングルステップデバイス、マルチステップデバイス)、適応症別(自己免疫疾患、感染症、代謝異常)、エンドユーザー別(病院、通院外科診療所、専門クリニック)

• 英文タイトル:Lyophilized Injectable Drugs Market (Type of Packaging -Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; Type of Delivery - Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; Indication - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions; End user - Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transparency Market Researchが調査・発行した産業分析レポートです。凍結乾燥注射製剤の世界市場分析・規模・シェア・成長・動向・予測:包装の種類別(使い捨てバイアル、ポイントオブケア再構成、特殊包装)、デリバリータイプ別(プレフィル希釈剤シリンジ、専用の再構成型デバイス、シングルステップデバイス、マルチステップデバイス)、適応症別(自己免疫疾患、感染症、代謝異常)、エンドユーザー別(病院、通院外科診療所、専門クリニック) / Lyophilized Injectable Drugs Market (Type of Packaging -Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; Type of Delivery - Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; Indication - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions; End user - Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 / TPM-C03004資料のイメージです。• レポートコード:TPM-C03004
• 出版社/出版日:Transparency Market Research / 2019年2月18日
• レポート形態:英文、PDF、179ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥625,860 (USD5,795)▷ お問い合わせ
  Multi User¥949,860 (USD8,795)▷ お問い合わせ
  Global Site License¥1,273,860 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、凍結乾燥注射製剤の世界市場について調べ、凍結乾燥注射製剤の世界規模、市場動向、市場環境、包装の種類別(使い捨てバイアル、ポイントオブケア再構成、特殊包装)分析、デリバリータイプ別(プレフィル希釈剤シリンジ、専用の再構成型デバイス、シングルステップデバイス、マルチステップデバイス)分析、適応症別(自己免疫疾患、感染症、代謝異常)分析、エンドユーザー別(病院、通院外科診療所、専門クリニック)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・凍結乾燥注射製剤の世界市場動向
・凍結乾燥注射製剤の世界市場環境
・凍結乾燥注射製剤の世界市場規模
・凍結乾燥注射製剤の世界市場規模:包装の種類別(使い捨てバイアル、ポイントオブケア再構成、特殊包装)
・凍結乾燥注射製剤の世界市場規模:デリバリータイプ別(プレフィル希釈剤シリンジ、専用の再構成型デバイス、シングルステップデバイス、マルチステップデバイス)
・凍結乾燥注射製剤の世界市場規模:適応症別(自己免疫疾患、感染症、代謝異常)
・凍結乾燥注射製剤の世界市場規模:エンドユーザー別(病院、通院外科診療所、専門クリニック)
・凍結乾燥注射製剤の世界市場:地域別市場規模・分析
・凍結乾燥注射製剤の北米市場規模・予測
・凍結乾燥注射製剤のアメリカ市場規模・予測
・凍結乾燥注射製剤の中南米市場規模・予測
・凍結乾燥注射製剤のヨーロッパ市場規模・予測
・凍結乾燥注射製剤のアジア市場規模・予測
・凍結乾燥注射製剤の日本市場規模・予測
・凍結乾燥注射製剤の中国市場規模・予測
・凍結乾燥注射製剤のインド市場規模・予測
・凍結乾燥注射製剤の中東市場規模・予測
・凍結乾燥注射製剤のアフリカ市場規模・予測
・競争状況・関連企業情報

Lyophilized Injectable Drugs Market – Overview

This report analyzes the current and future scenario of the global lyophilized injectable drugs market. Lyophilization is a freeze drying process used for the removal of water from the final product. In lyophilization, output products are frozen under high vacuum. The lyophilization process is used in the biotechnological and pharmaceutical manufacturing industries for the production of good quality products with expanded lifespan. The global lyophilized injectable drugs market is driven by rise in chronic health conditions, increase in geriatric and overall population with cardiac and neurological defects, expansion of pipeline of lyophilized injectable drugs, reduced risk of administration of lyophilized injectable drugs with prefilled diluent syringes, and technological advancements. Moreover, lyophilization enables safe transit and storage of these substances until their end use. Rise in quality concerns has made lyophilization of injectable drugs quite essential. Lyophilized injectable drugs have proven to be safer and effective to administer after storing for a long period than other dried products. This is expected to drive the global lyophilized injectable drugs market during the forecast period.

The global lyophilized injectable drugs market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on type of packaging, type of delivery, indication, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global lyophilized injectable drugs market.

Global Lyophilized Injectable Drugs Market: Key Segments

In terms of type of packaging, the global market has been segmented into single-use vials, point-of-care reconstitution, specialty packaging, and others. Based on type of delivery, the market has been classified into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. Based on indication, the global lyophilized injectable drugs market has been categorized into autoimmune diseases, infectious diseases, metabolic conditions, and others. In terms of end-user, the market has been divided into hospitals, ambulatory surgical centers, specialty clinics, and others. The market size and forecast for each of these segments have been provided in terms of US$ Mn for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Lyophilized Injectable Drugs Market: Regional Outlook

Geographically, the global lyophilized injectable drugs market has been segmented into five major regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global lyophilized injectable drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players in the global market are B. Braun Melsungen AG, Baxter, Becton, Dickinson and Company, Mylan N.V., Schott AG, SHL Group, Vetter Pharma, CIRON Drugs & Pharmaceuticals Pvt. Ltd, and Jubilant HollisterStier.

The global lyophilized injectable drugs market has been segmented as below:

Global Lyophilized Injectable Drugs Market, by Type of Packaging
Single-use Vials
Point-of-Care Reconstitution
Specialty Packaging
Others
Global Lyophilized Injectable Drugs Market, by Type of Delivery
Prefilled Diluent Syringes
Proprietary Reconstitution Devices
Single-step Devices
Multi-step Devices
Global Lyophilized Injectable Drugs Market, by Indication
Autoimmune Diseases
Infectious Diseases
Metabolic Conditions
Others
Global Lyophilized Injectable Drugs Market, by End-user
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Global Lyophilized Injectable Drugs Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

レポート目次

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Lyophilized Injectable Drugs Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
3.2. Global Lyophilized Injectable Drugs Market: Market Snapshot

4. Market Overview
4.1. Global Lyophilized Injectable Drugs Market: Type of Packaging Overview
4.2. Global Lyophilized Injectable Drugs Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.6. Restraints
4.7. Opportunities
4.8. Global Lyophilized Injectable Drugs Market Revenue Projections (US$ Mn), 2016–2026

5. Key Insights
5.1. Key Merger and Acquisitions
5.2. Regulatory Scenario, by Country/Region

6. Global Lyophilized Injectable Drugs Market Analysis, by Type of Packaging
6.1. Introduction
6.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
6.2.1. Single-use Vials
6.2.2. Point-of-Care Reconstitution
6.2.3. Specialty Packaging
6.2.4. Others
6.3. Global Lyophilized Injectable Drugs Market Analysis, by Type of Packaging
6.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Type of Packaging

7. Global Lyophilized Injectable Drugs Market Analysis, by Type of Delivery
7.1. Introduction
7.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
7.2.1. Prefilled Diluent Syringes
7.2.2. Proprietary Reconstitution Devices
7.2.3. Single-step Devices
7.2.4. Multi-step Devices
7.3. Global Lyophilized Injectable Drugs Market Analysis, by Type of Delivery
7.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Type of Delivery

8. Global Lyophilized Injectable Drugs Market Analysis, by Indication
8.1. Introduction
8.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Indication
8.2.1. Autoimmune Diseases
8.2.2. Infectious Diseases
8.2.3. Metabolic Conditions
8.2.4. Others
8.3. Global Lyophilized Injectable Drugs Market Analysis, by Indication
8.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Indication

9. Global Lyophilized Injectable Drugs Market Analysis, by End-user
9.1. Introduction
9.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by End-user
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
9.2.3. Specialty Clinics
9.2.4. Others
9.3. Global Lyophilized Injectable Drugs Market Analysis, by End-user
9.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by End-user

10. Global Lyophilized Injectable Drugs Market Analysis, by Region
10.1. Global Lyophilized Injectable Drugs Market Size and Forecast, by Region, 2016–2026
10.1.1. North America
10.1.2. Europe
10.1.3. Asia Pacific
10.1.4. Latin America
10.1.5. Middle East & Africa
10.2. Global Lyophilized Injectable Drugs Market Analysis, by Region
10.3. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Region

11. North America Lyophilized Injectable Drugs Market Analysis
11.1. North America Lyophilized Injectable Drugs Market
11.2. North America Lyophilized Injectable Drugs Market Overview
11.3. North America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
11.3.1. Single-use Vials
11.3.2. Point-of-Care Reconstitution
11.3.3. Specialty Packaging
11.3.4. Others
11.4. North America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
11.4.1. Prefilled Diluent Syringes
11.4.2. Proprietary Reconstitution Devices
11.4.3. Single-step Devices
11.4.4. Multi-step Devices
11.5. North America Lyophilized Injectable Drugs Market Size and Forecast, by Indication
11.5.1. Autoimmune Diseases
11.5.2. Infectious Diseases
11.5.3. Metabolic Conditions
11.5.4. Others
11.6. North America Lyophilized Injectable Drugs Market Size and Forecast, by End-user
11.6.1. Hospitals
11.6.2. Ambulatory Surgical Centers
11.6.3. Specialty Clinics
11.6.4. Others
11.7. North America Lyophilized Injectable Drugs Market Forecast, by Country
11.7.1. U.S.
11.7.2. Canada
11.8. North America Lyophilized Injectable Drugs Market Attractiveness Analysis
11.8.1. By Type of Packaging
11.8.2. By Type of Delivery
11.8.3. By Indication
11.8.4. By End-user
11.8.5. By Country

12. Europe Lyophilized Injectable Drugs Market Analysis
12.1. Europe Lyophilized Injectable Drugs Market
12.2. Europe Lyophilized Injectable Drugs Market Overview
12.3. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
12.3.1. Single-use Vials
12.3.2. Point-of-Care Reconstitution
12.3.3. Specialty Packaging
12.3.4. Others
12.4. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
12.4.1. Prefilled Diluent Syringes
12.4.2. Proprietary Reconstitution Devices
12.4.3. Single-step Devices
12.4.4. Multi-step Devices
12.5. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Indication
12.5.1. Autoimmune Diseases
12.5.2. Infectious Diseases
12.5.3. Metabolic Conditions
12.5.4. Others
12.6. Europe Lyophilized Injectable Drugs Market Size and Forecast, by End-user
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Specialty Clinics
12.6.4. Others
12.7. Europe Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
12.7.1. U.K.
12.7.2. France
12.7.3. Germany
12.7.4. Spain
12.7.5. Italy
12.7.6. Rest of Europe
12.8. Europe Lyophilized Injectable Drugs Market Attractiveness Analysis
12.8.1. By Type of Packaging
12.8.2. By Type of Delivery
12.8.3. By Indication
12.8.4. By End-user
12.8.5. By Country/Sub-region

13. Asia Pacific Lyophilized Injectable Drugs Market Analysis
13.1. Asia Pacific Lyophilized Injectable Drugs Market Key Findings
13.2. Asia Pacific Lyophilized Injectable Drugs Market Overview
13.3. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
13.3.1. Single-use Vials
13.3.2. Point-of-Care Reconstitution
13.3.3. Specialty Packaging
13.3.4. Others
13.4. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
13.4.1. Prefilled Diluent Syringes
13.4.2. Proprietary Reconstitution Devices
13.4.3. Single-step Devices
13.4.4. Multi-step Devices
13.5. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Indication
13.5.1. Autoimmune Diseases
13.5.2. Infectious Diseases
13.5.3. Metabolic Conditions
13.5.4. Others
13.6. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by End-user
13.6.1. Hospitals
13.6.2. Ambulatory Surgical Centers
13.6.3. Specialty Clinics
13.6.4. Others
13.7. Asia Pacific Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
13.7.1. China
13.7.2. India
13.7.3. Japan
13.7.4. Australia & New Zealand
13.7.5. Rest of Asia Pacific
13.8. Asia Pacific Lyophilized Injectable Drugs Market Attractiveness Analysis
13.8.1. By Type of Packaging
13.8.2. By Type of Delivery
13.8.3. By Indication
13.8.4. By End-user
13.8.5. By Country/Sub-region

14. Latin America Lyophilized Injectable Drugs Market Analysis
14.1. Latin America Lyophilized Injectable Drugs Market Key Findings
14.2. Latin America Lyophilized Injectable Drugs Market Overview
14.3. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
14.3.1. Single-use Vials
14.3.2. Point-of-Care Reconstitution
14.3.3. Specialty Packaging
14.3.4. Others
14.4. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
14.4.1. Prefilled Diluent Syringes
14.4.2. Proprietary Reconstitution Devices
14.4.3. Single-step Devices
14.4.4. Multi-step Devices
14.5. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Indication
14.5.1. Autoimmune Diseases
14.5.2. Infectious Diseases
14.5.3. Metabolic Conditions
14.5.4. Others
14.6. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by End-user
14.6.1. Hospitals
14.6.2. Ambulatory Surgical Centers
14.6.3. Specialty Clinics
14.6.4. Others
14.7. Latin America Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Lyophilized Injectable Drugs Market Attractiveness Analysis
14.8.1. By Type of Packaging
14.8.2. By Type of Delivery
14.8.3. By Indication
14.8.4. By End-user
14.8.5. By Country/Sub-region

15. Middle East & Africa Lyophilized Injectable Drugs Market Analysis
15.1. Middle East & Africa Lyophilized Injectable Drugs Market
15.2. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging
15.2.1. Single-use Vials
15.2.2. Point-of-Care Reconstitution
15.2.3. Specialty Packaging
15.2.4. Others
15.3. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
15.3.1. Prefilled Diluent Syringes
15.3.2. Proprietary Reconstitution Devices
15.3.3. Single-step Devices
15.3.4. Multi-step Devices
15.4. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Indication
15.4.1. Autoimmune Diseases
15.4.2. Infectious Diseases
15.4.3. Metabolic Conditions
15.4.4. Others
15.5. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by End-user
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.5.4. Others
15.6. Middle East & Africa Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness Analysis
15.7.1. By Type of Packaging
15.7.2. By Type of Delivery
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1. Company Profiles
16.1.1. B. Braun Melsungen AG
16.1.1.1. Overview (HQ, Employee Strength, Business Segments)
16.1.1.2. Financials
16.1.1.3. Recent Developments
16.1.1.4. Strategy
16.1.2. Baxter
16.1.2.1. Overview (HQ, Employee Strength, Business Segments)
16.1.2.2. Financials
16.1.2.3. Recent Developments
16.1.2.4. Strategy
16.1.3. Becton, Dickinson and Company
16.1.3.1. Overview (HQ, Employee Strength, Business Segments)
16.1.3.2. Financials
16.1.3.3. Recent Developments
16.1.3.4. Strategy
16.1.4. Mylan N.V.
16.1.4.1. Overview (HQ, Employee Strength, Business Segments)
16.1.4.2. Financials
16.1.4.3. Recent Developments
16.1.4.4. Strategy
16.1.5. Schott AG
16.1.5.1. Overview (HQ, Employee Strength, Business Segments)
16.1.5.2. Financials
16.1.5.3. Recent Developments
16.1.5.4. Strategy
16.1.6. SHL Group
16.1.6.1. Overview (HQ, Employee Strength, Business Segments)
16.1.6.2. Financials
16.1.6.3. Recent Developments
16.1.6.4. Strategy
16.1.7. Vetter Pharma
16.1.7.1. Overview (HQ, Employee Strength, Business Segments)
16.1.7.2. Financials
16.1.7.3. Recent Developments
16.1.7.4. Strategy
16.1.8. CIRON Drugs & Pharmaceuticals Pvt. Ltd.
16.1.8.1. Overview (HQ, Employee Strength, Business Segments)
16.1.8.2. Financials
16.1.8.3. Recent Developments
16.1.8.4. Strategy
16.1.9. Jubilant HollisterStier
16.1.9.1. Overview (HQ, Employee Strength, Business Segments)
16.1.9.2. Financials
16.1.9.3. Recent Developments
16.1.9.4. Strategy

List of Tables

TABLE 1 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 2 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 3 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 4 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 5 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
TABLE 6 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
TABLE 7 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 8 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 9 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 10 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 11 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 12 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 13 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 14 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 15 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 16 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 17 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 18 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 19 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 20 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 21 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 22 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 23 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 24 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 25 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 26 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 27 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 28 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 29 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 30 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026